This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

HPV

  1. This brief summarizes a comprehensive review and assessment of current, published evidence for a single-dose HPV vaccination schedule. The review was undertaken by researchers in the Single-Dose HPV Vaccine Evaluation Consortium.
    Published: December 2019
    Type: Resource Page
  2. Imagine you need treatment for cervical precancer.
    Published: November 2019
    Type: Article
  3. The primary objective of this review is to summarize and assess the current evidence that could support a change to a single-dose schedule of HPV vaccine. The review also aims to identify gaps that remain in determining whether a single dose could be sufficiently protective to have a major impact against HPV infection and its sequelae, within the context of immunization programs.
    Published: June 2019
    Type: Resource Page
  4. Vaccines are one of the most effective global public health interventions ever.
    Published: April 2019
    Type: Article
  5. When more vaccine manufacturers are able to enter the market, supply increases while cost decreases. PATH supports emerging market vaccine manufacturers to do just that, improving access to lifesaving vaccines.
    Published: March 2019
    Type: Article
  6. The United States has a long history of leadership in global immunization. This educational fact sheet created by PATH and several advocacy partners highlights US government efforts in global immunization, including support for Gavi, the Vaccine Alliance; UNICEF; and the World Health Organization, as well as immunization activities carried out by the US Agency for International Development, US Department of Defense, and various agencies within the Department of Health and Human Services.
    Published: March 2019
    Type: Resource Page
  7. There is broad recognition of the growing and inequitable burden of cervical cancer in low-resource countries, and uptake of new screening and treatment alternatives for adult women and human papillomavirus (HPV) vaccines for young adolescent girls is on the rise. For the first time in history the elimination of the disease is within reach, and on May 19, 2018, WHO Director-General, Dr. Tedros Adhanom Ghebreyesus made a global call for action on cervical cancer elimination. This fact sheet summarizes PATH's current work and future priorities.
    Published: July 2018
    Type: Resource Page
  8. Aisha was wearing her blue school uniform and wiping tears from her face. She’d just been vaccinated, but it wasn’t the shot that upset her. She was crying because her mother died of the very disease she was being protected from—cervical cancer.
    Published: June 2018
    Type: Article
  9. Leading health and research institutions come together to evaluate the evidence for potential single-dose HPV vaccination schedule
    Published: January 2018
    Type: Announcement
  10. PATH’s Scale-Up project works to expand the use of human papillomavirus (HPV) testing for cervical cancer prevention. Based on PATH’s experience implementing the careHPV™ test in Central America, these tools provide guidance for organizing a quality assurance program to screening programs adopting the careHPV test.
    Published: November 2017
    Type: Resource Page
Load more